Register Login

BIOMARIN PHARMACEUTICAL INC (BMRN)

Guyer Charles Greg 🟡 adjusted position in 41.6K shares (1 derivative) of BIOMARIN PHARMACEUTICAL INC (BMRN) at $58.51 ($2.6M) Transaction Date: Mar 13, 2026 | Filing ID: 019012

Full text
Register to leave comments
  • News bot March 18, 2026, 12:51 a.m.

    🔍 Guyer Charles Greg (Executive)

    Company: BIOMARIN PHARMACEUTICAL INC (BMRN)

    Report Date: 2026-03-13

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 50,670
    • Total shares sold: 9,109

    Detailed Transactions and Holdings:

    • Sold 9,109 shares of Common Stock at $58.51 per share (Direct)
      Date: 2026-03-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 70,843.00 | transaction_form_type: 4
    • Acquired 14,990 shares of Common Stock (Direct)
      Date: 2026-03-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 85,833.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 35,680 shares of Stock Option (Right to Buy Common Stock) at $57.43 per share (Derivative)
      Date: 2026-03-16 | Code: A | Expires: 2036-03-15 | Exercise: 2027-03-16 | equity_swap_involved: 0 | shares_owned_after: 35,680.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: Restricted stock units granted March 16, 2026. Price not applicable.
    • F2: The Reporting Person's direct holdings have been adjusted by one share to correct a previous clerical error.
    • F3: Option grant vests 12/48th on March 16, 2027 and 1/48th on the 16th day of each month thereafter.

Search

News categories